Jul 9, 2014, 12:00 PM by Michael Croft

Wall Street Journal | In an oped in the Wall Street Journal, Francis Collins gives his view of the "broad horizon" before biomedical research today.

Jul 9, 2014, 12:00 PM by Michael Croft

Bio-IT World News Brief | If you’ve got an idea for a next-gen sequencing analysis pipeline—and you’re creative on camera—Appistry invites you to participate in its inaugural Appistry Pipeline Challenge. The winning group will receive $70,000 worth of hardware and software to build its pipeline.

Jul 9, 2014, 00:00 AM by Michael Croft

PHILADELPHIA, PA, UNITED STATES - Jul 9, 2014 - The Intellectual Property and Science business of Thomson Reuters,  the world’s leading provider of intelligent information for businesses and professionals, today released a three-part analysis on the depression drug market following the 25th anniversary of the U

Jul 8, 2014, 08:00 AM by Michael Croft

New York Times | AbbVie raised its bid for Shire this morning to a cash and stock offering worth about $87.66 per share, or $51.6 billion total.

Jul 8, 2014, 00:00 AM by Michael Croft

CHARLOTTESVILLE, VA, UNITED STATES - Jul 8, 2014 - FOR IMMEDIATE RELEASE   Study of InSpark Technologies' Pattern Identification System Published in the Journal of Diabetes Science and TechnologyData demonstrates the utility of InSpark's advanced blood glucose pattern recognition technology

Jul 8, 2014, 00:00 AM by Michael Croft

BOSTON, MA - Jul 8, 2014 - Boston Children's Hospital today announced the creation of two new annual awards that will be conferred at the Global Pediatric Innovation Summit + Awards, Taking on Tomorrow  (#PedInno14), taking place October 30-31, 2014, at the Seaport World Trade Center in Boston

Jul 7, 2014, 11:35 AM by Michael Croft

Bio-IT World | This morning, the European Commission received an open letter signed by 154 European neuroscientists, expressing concern over the direction of the Human Brain Project that was launched last year.

Jul 7, 2014, 00:00 AM by Michael Croft

CAMBRIDGE, MA - Jul 7, 2014 - NextCODE Health, which puts whole-genome analysis in the hands of clinicians and researchers worldwide, today announced the start of a partnership with the Academic Centre on Rare Diseases (ACoRD) at University College Dublin

Jul 3, 2014, 12:00 PM by Michael Croft

NBC News | Yesterday the National Institutes of Health launched the Undiagnosed Diseases Network, a four-year, $43 million program focused on the rarest of diseases, many afflicting fewer than 50 people worldwide.

Jul 3, 2014, 12:00 PM by Michael Croft

Bio-IT World | Guest Commentary | The global pharmaceutical industry faces challenges that require it to look beyond the status quo and develop a fresh transformative vision for the future. Many pharmas are now looking to consolidate vendors as they embark on restructuring and cost reduction efforts.

Jul 3, 2014, 12:00 PM by Michael Croft

South China Morning Post | The China Food & Drug Administration approved two sequencers from BGI--the BGISEQ-1000 and BGISEQ-100--and a diagnostic kit for prenatal testing of "high risk" pregnancies.

Jul 1, 2014, 07:10 AM by Michael Croft

Bio-IT World | Euretos is certainly not the first company to recognize the problems researchers have processing and keeping up to date with the latest research. While there’s ever more data pouring from researchers’ lab instruments, there’s also an ongoing flow to manage from journals and other publications. Euretos has launched a cloud platform called BRAIN: the Bio Relations and Intelligence Network, that allows researchers to mine and connect data from public and private published sources in new ways.

Jul 1, 2014, 06:00 AM by Michael Croft

Bio-IT World | Outsourcing options in biotech have been growing. CROs and other labs offer a wide range of services. But what if you aren’t interested in a partner as much as simply automated experiments? Don’t outsource experiments to another lab; let the robots do them!

Jul 1, 2014, 00:00 AM by Michael Croft

WARSAW, POLAND - Jul 1, 2014 - Principal Investigators® (www.principalinvestigators.com), the world’s first place for clinical trial & patient referral offers, announced the global availability of its online platform designed specifically to connect Medical Doctors with Pharma and R&D companies involved in clinical studies

Jul 1, 2014, 00:00 AM by Michael Croft

CRUMLIN, UNITED KINGDOM - Jul 1, 2014 - A new Randox External Quality Assurance (EQA) programme monitoring Ammonia and Ethanol will be available on RIQAS from September 2014

Jul 1, 2014, 00:00 AM by Michael Croft

NEW YORK, NY - Jul 1, 2014 - TEMIS, the leading provider of Semantic Content Enrichment solutions for the Enterprise, today announced the launch of Luxid® 7, the seventh generation of its flagship semantic content enrichment platform

Jul 1, 2014, 00:00 AM by Michael Croft

CRUMLIN, UNITED KINGDOM - Jul 1, 2014 - The TGA (Australia) has cleared a test developed by Randox Laboratories which allows assessment of the risk of patients developing Type 2 diabetes and Cardiovascular Disease

Jul 1, 2014, 00:00 AM by Michael Croft

REDWOOD SHORES, CA, UNITED STATES - Jul 1, 2014 - Model N, Inc. (NYSE: MODN), the leading revenue management provider to the life sciences and technology industries, today announced the expansion of the Model N Regulatory Update Program - a program that every Model N Government Compliance customer is automatically enrolled in at no extra charge

Jun 30, 2014, 14:00 PM by Michael Croft

Bio-IT World Brief | In a comment on FDA's blog on Thursday, Jeffrey Shuren, Director of FDA’s Center for Devices and Radiological Health, again restated the Agency's concern with 23andMe's direct-to-consumers genomic tests. The issue, 
"at the heart of our five-year effort to work with the firm 23andMe," he says, is accuracy.

Jun 30, 2014, 12:15 PM by Michael Croft

Bio-IT World | The human reference genome has served geneticists well since the completion of the Human Genome Project in 2003. But with new sequencing technologies and a unique cell line, a team attached to the Genome Reference Consortium is tinkering with a new "platinum genome" based on a single haploid sample, a reference that could better represent structural variants and the range of human haplotypes.